nach oben

Wiener klinische Wochenschrift

Erschienen in:

14.10.2022 | original article

Minimally invasive surgical aortic valve replacement versus transfemoral transcatheter aortic valve implantation in low-risk octogenarians

Observational, retrospective and single-center study

verfasst von: Tadeja Kolar, Matjaž Bunc, Matija Jelenc, Simon Terseglav, Aleša Kotnik, Nikola Lakič

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2023

Einloggen, um Zugang zu erhalten

Summary

Background

The aim of this study was to compare short-term and mid-term outcomes in low-risk octogenarian population treated with transfemoral transcatheter aortic valve implantation (tf-TAVI) or minimally invasive aortic valve replacement (mini-AVR) for severe aortic stenosis.

Methods

In this single-center, retrospective cohort study we gathered data on low-risk (Society of Thoracic Surgeons [STS] score < 4%) octogenarians before and after tf-TAVI and mini-AVR performed between January 2013 and May 2019; follow-up was completed in May 2022. Short-term outcomes were hospital length of stay, in-hospital all-cause mortality and other major postoperative outcomes. Mid-term clinical outcomes were 1‑year and 3‑year all-cause mortality. Propensity score-based matching was performed.

Results

In total 106 patients were matched, resulting in 53 pairs. In-hospital complications were similar between the matched groups of patients with the exception of mild and moderate paravalvular leak (mini-AVR vs. tf-TAVI: mild PVL: 3.8% vs. 45.3%, p < 0.001; moderate PVL: 0% vs. 3.8%, p = 0.4952) and of postprocedural acute kidney injury that was more frequent in mini-AVR group (mini-AVR vs. tf-TAVI: 22.6% vs. 5.7%; p = 0.023). Hospital length of stay (p = 0.239) and in-hospital mortality (p = 0.495) did not differ between groups. The 1-year and 3‑year all-cause mortality Kaplan-Meier estimates were similar between mini-AVR and tf-TAVI.

Conclusion

In the present study on low-risk octogenarians, transfemoral TAVI and minimally invasive AVR showed comparable short-term and mid-term results. Both procedures are deemed safe and effective. Larger RCTs will be required to determine which low-risk patients will benefit most from TAVI.

Vorheriger Artikel Frailty as a predictor of mortality and readmission rate in secondary mitral regurgitation

Nächster Artikel Ultrasound utilization for implantation of cardiac implantable electronic devices

Cahill TJ, Chen M, Hayashida K, Latib A, Modine T, Piazza N, et al. Transcatheter aortic valve implantation: current status and future perspectives. Eur Heart J. 2018;39(28):2625–34.CrossRefPubMed

Thyregod HGH, Steinbrüchel DA, Ihlemann N, Nissen H, Kjeldsen BJ, Petursson P, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis 1‑year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65(20):2184–94.CrossRefPubMed

Serruys PW, Modolo R, Reardon M, Miyazaki Y, Windecker S, Popma J, et al. One-year outcomes of patients with severe aortic stenosis and an STS PROM of less than three percent in the SURTAVI trial. EuroIntervention. 2018;14(8):877–83.CrossRefPubMed

Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380(18):1695–705.CrossRefPubMed

Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O’Hair D, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380(18):1706–15.CrossRefPubMed

Cosgrove DM, Sabik JF, Navia JL. Minimally invasive valve operations. Ann Thorac Surg. 1998;65(6):1535–9.CrossRefPubMed

Bacco LD, Miceli A, Glauber M. Minimally invasive aortic valve surgery. J Thorac Dis. 2021;13(3):1945–59.CrossRefPubMedPubMedCentral

Brown ML, McKellar SH, Sundt TM, Schaff HV. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2009;137(3):670–679.e5.CrossRefPubMed

Glauber M, Miceli A, Gilmanov D, Ferrarini M, Bevilacqua S, Farneti PA, et al. Right anterior minithoracotomy versus conventional aortic valve replacement: a propensity score matched study. J Thorac Cardiovasc Surg. 2013;145(5):1222–6.CrossRefPubMed

10.

Salmasi MY, Hamilton H, Rahman I, Chien L, Rival P, Benedetto U, et al. Mini-sternotomy vs right anterior thoracotomy for aortic valve replacement. J Card Surg. 2020;35(7):1570–82.CrossRef

11.

Al-Maisary S, Farag M, Gussinklo WHT, Kremer J, Pleger ST, Leuschner F, et al. Are sutureless and rapid-deployment aortic valves a serious alternative to TA-TAVI? A matched-pairs analysis. J Clin Med. 2021;10(14):3072.CrossRefPubMedPubMedCentral

12.

Miceli A, Gilmanov D, Murzi M, Marchi F, Ferrarini M, Cerillo AG, et al. Minimally invasive aortic valve replacement with a sutureless valve through a right anterior mini-thoracotomy versus transcatheter aortic valve implantation in high-risk patients. Eur J Cardiothorac Surg. 2016;49(3):960–5.CrossRefPubMed

13.

Paparella D, Santarpino G, Malvindi PG, Moscarelli M, Marchese A, Guida P, et al. Minimally invasive surgical versus transcatheter aortic valve replacement: a multicenter study. Int J Cardiol Heart Vasc. 2019;23:100362.PubMedPubMedCentral

14.

Witberg G, Landes U, Lador A, Yahav D, Kornowski R. Meta-analysis of transcatheter aortic valve implantation versus surgical aortic valve replacement in patients at low surgical risk. EuroIntervention. 2019;15(12):e1047–56.CrossRefPubMed

15.

Kappetein AP, Head SJ, Généreux P, Piazza N, van Mieghem NM, Blackstone EH, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the valve academic research consortium‑2 consensus document. Eur Heart J. 2012;33(19):2403–18.CrossRefPubMed

16.

Bekeredjian R, Szabo G, Balaban Ü, Bleiziffer S, Bauer T, Ensminger S, et al. Patients at low surgical risk as defined by the society of thoracic surgeons score undergoing isolated interventional or surgical aortic valve implantation: in-hospital data and 1‑year results from the German aortic valve registry (GARY). Eur Heart J. 2018;40(17):1323–30.CrossRef

17.

Schaefer A, Schofer N, Goßling A, Seiffert M, Schirmer J, Deuschl F, et al. Transcatheter aortic valve implantation versus surgical aortic valve replacement in low-risk patients: a propensity score-matched analysis. Eur J Cardiothorac Surg. 2019;56(6):1131–9.CrossRefPubMed

18.

Brízido C, Madeira M, Brito J, Madeira S, Teles RC, Raposo L, et al. Surgical versus transcatheter aortic valve replacement in low-risk patients: a long-term propensity score-matched analysis. Catheter Cardiovasc Interv. 2021;98(7):E1033–43.CrossRefPubMed

19.

Doyle MP, Woldendorp K, Ng M, Vallely MP, Wilson MK, Yan TD, et al. Minimally-invasive versus transcatheter aortic valve implantation: systematic review with meta-analysis of propensity-matched studies. J Thorac Dis. 2021;13(3):1671–83.CrossRefPubMedPubMedCentral

20.

Laakso T, Laine M, Moriyama N, Dahlbacka S, Airaksinen J, Virtanen M, et al. Impact of paravalvular regurgitation on the mid-term outcome after transcatheter and surgical aortic valve replacement. Eur J Cardiothorac Surg. 2020;58(6):1145–52.CrossRefPubMed

21.

Makkar RR, Thourani VH, Mack MJ, Kodali SK, Kapadia S, Webb JG, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382(9):799–809.CrossRefPubMed

22.

Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374(17):1609–20.CrossRefPubMed

23.

Reardon MJ, Mieghem NMV, Popma JJ, Kleiman NS, Søndergaard L, Mumtaz M, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–31.CrossRefPubMed

24.

Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. Impact of paravalvular aortic regurgitation after transcatheter aortic valve implantation on survival. Int J Cardiol. 2016;221:46–51.CrossRefPubMed

25.

Ando T, Briasoulis A, Telila T, Afonso L, Grines CL, Takagi H. Does mild paravalvular regurgitation post transcatheter aortic valve implantation affect survival? A meta-analysis. Catheter Cardiovasc Interv. 2018;91(1):135–47.CrossRefPubMed

26.

Gomes B, Geis NA, Chorianopoulos E, Meder B, Leuschner F, Katus HA, et al. Improvements of procedural results with a new-generation self-expanding transfemoral aortic valve prosthesis in comparison to the old-generation device. J Interv Cardiol. 2017;30(1):72–8.CrossRefPubMed

27.

Yoshijima N, Yanagisawa R, Hase H, Tanaka M, Tsuruta H, Shimizu H, et al. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: insights from the Japanese multicenter OCEAN-TAVI registry. Catheter Cardiovasc Interv. 2020;95(1):35–44.CrossRefPubMed

28.

Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, Fontana GP, Dewey TM, Thourani VH, Pichard AD, Fischbein M, Szeto WY, Lim S, Greason KL, Teirstein PS, Malaisrie SC, Douglas PS, Hahn RT, Whisenant B, Zajarias A, Wang D, Akin JJ, Anderson WN, Leon MB, PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686–95.CrossRefPubMed

29.

Hagar A, Li Y, Wei X, Peng Y, Xu Y, Ou Y, et al. Incidence, predictors, and outcome of paravalvular leak after transcatheter aortic valve implantation. J Interv Cardiol. 2020;2020:8249497.CrossRefPubMedPubMedCentral

30.

Bhushan S, Huang X, Li Y, He S, Mao L, Hong W, et al. Paravalvular leak after trancatheter aortic valve implantation its incidence, diagnosis, clinical implications, prevention, management and future perspectives: a review article. Curr Probl Cardiol. 2021;47(10):100957. https://doi.org/10.1016/j.cpcardiol.2021.100957.CrossRefPubMed

31.

Siddiqui WJ, Alvarez C, Aslam M, Bakar A, Khan MH, Aslam A, et al. Meta-analysis comparing outcomes and need for renal replacement therapy of transcatheter aortic valve implantation versus surgical aortic valve replacement. Am J Cardiol. 2018;122(3):468–76.CrossRefPubMed

32.

Hirji SA, Funamoto M, Lee J, Val FRD, Kolkailah AA, McGurk S, et al. Minimally invasive versus full sternotomy aortic valve replacement in low-risk patients: which will stand against transcatheter aortic valve replacement? Surgery. 2018;164(2):282–7.CrossRefPubMed

33.

Wilson TW, Horns JJ, Sharma V, Goodwin ML, Kagawa H, Pereira SJ, et al. Minimally invasive versus full sternotomy SAVR in the era of TAVR: an institutional review. J Clin Med. 2022;11(3):547.CrossRefPubMedPubMedCentral

34.

Sinning JM, Ghanem A, Steinhäuser H, Adenauer V, Hammerstingl C, Nickenig G, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. Jacc Cardiovasc Interv. 2010;3(11):1141–9.CrossRefPubMed

35.

Zaleska-Kociecka M, Dabrowski M, Stepinska J. Acute kidney injury after transcatheter aortic valve replacement in the elderly: outcomes and risk management. Clin Interv Aging. 2019;14:195–201.CrossRefPubMedPubMedCentral

36.

Moriyama N, Laakso T, Raivio P, Dahlbacka S, Kinnunen EM, Juvonen T, et al. Acute kidney injury following aortic valve replacement in patients without chronic kidney disease. Can J Cardiol. 2021;37(1):37–46.CrossRefPubMed

37.

Kolte D, Vlahakes GJ, Palacios IF, Sakhuja R, Passeri JJ, Inglessis I, et al. Transcatheter versus surgical aortic valve replacement in low-risk patients. J Am Coll Cardiol. 2019;74(12):1532–40.CrossRefPubMed

38.

Rosato S, Santini F, Barbanti M, Biancari F, D’Errigo P, Onorati F, et al. Transcatheter aortic valve implantation compared with surgical aortic valve replacement in low-risk patients. Circ Cardiovasc Interv. 2018;9(5):e3326.

39.

Santarpino G, Lorusso R, Moscarelli M, Mikus E, Wisniewski K, Dell’Aquila AM, et al. Sutureless versus transcatheter aortic valve replacement: a multicenter analysis of “real-world” data. J Cardiol. 2022;79(1):121–6.CrossRefPubMed

40.

Sammour Y, Krishnaswamy A, Kumar A, Puri R, Tarakji KG, Bazarbashi N, et al. Incidence, predictors, and implications of permanent pacemaker requirement after transcatheter aortic valve replacement. Jacc Cardiovasc Interv. 2021;14(2):115–34.CrossRefPubMed

41.

Jørgensen TH, Thyregod HGH, Ihlemann N, Nissen H, Petursson P, Kjeldsen BJ, et al. Eight-year outcomes for patients with aortic valve stenosis at low surgical risk randomized to transcatheter vs. surgical aortic valve replacement. Eur Heart J. 2021;42(30):2912–9.CrossRefPubMedPubMedCentral

Titel: Minimally invasive surgical aortic valve replacement versus transfemoral transcatheter aortic valve implantation in low-risk octogenarians
Observational, retrospective and single-center study
verfasst von: Tadeja Kolar
Matjaž Bunc
Matija Jelenc
Simon Terseglav
Aleša Kotnik
Nikola Lakič
Publikationsdatum: 14.10.2022
Verlag: Springer Vienna
Erschienen in: Wiener klinische Wochenschrift / Ausgabe 23-24/2023
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI: https://doi.org/10.1007/s00508-022-02094-z

Springer Medizin Österreich

Summary

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 23-24/2023

Hypertensive response to exercise, hypertension and heart failure with preserved ejection fraction (HFpEF)—a continuum of disease?

MUW researcher of the month

Die Wiener Medizin und der akademische Antisemitismus

Low-density lipoprotein cholesterol reduction with immediate combination therapy of statin and ezetimibe compared to statin monotherapy after percutaneous coronary intervention

Integrating avatar technology into a telemedicine application in heart failure patients

Sex differences in the management and outcome of acute coronary syndrome—Still an issue of equal treatment?